| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e75a9e791c37dcf775732b488493767b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6e6c2b91e6bba5d3eeb99f9e6dacda2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd6551a14ec1a165d0b10f77afad8886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab507ebcd8aa0639402312b9db5b77e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c788f36b817158481b0b320de068ac53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b37d3d0069c3b207c3f52298811ee75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f63be9975cfac65b3fa189048b0a3de1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fa285d172a69803e48678386ca54ac4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate |
2006-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e37cea407ff2947ba3f549e4ed9fe4dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b48faf7ec61bd36e4b885fb7d48dca0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2d37044fbb283301c510d289016371b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfdea9b574621fde1b248d258c915972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fb52f60d0a4b3bffb3c483ca78db7c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba16443e05a4624d36771ed76de4f2b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bd0031a176d3e727cc135a36c99548d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f936d93dcd33df3ba9c3e9bba5957e |
| publicationDate |
2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007259942-A1 |
| titleOfInvention |
Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods |
| abstract |
This invention is directed to pyrimidine and indolone derivatives which are selective antagonists for the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety. This invention also provides a method of treating depression and/or anxiety in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GAL3 receptor antagonist. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007135509-A1 |
| priorityDate |
2001-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |